Concepedia

Roland Frötschl

RF

Statistics

Publications

14

Citations

1K

H-Index

13

Active since

1990

Affiliations

Federal Institute for Drugs and Medical Devices(Current)

National Institute for Public Health and the Environment

Pfizer (United States)

National Institute of Health Sciences

Health Canada

Roland Frötschl is an author at Federal Institute for Drugs and Medical Devices specializing in pharmacy, toxicology, and genotoxicity assessment.

ORCID

Publications per year

1990–2021

14

Publications

14

Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest

Navin Sarin, Florian Engel, Ganna V. Kalayda et al. · PLoS ONE · 2017 · 172 citations · Full text

, , +17

Beet Yellows Closterovirus: Complete Genome Structure and Identification of a Leader Papain-like Thiol Protease

Alexey A. Agranovsky, Eugene V. Koonin, Vitaly Boyko et al. · Virology · 1994 · 169 citations

, , +12

IWGT report on quantitative approaches to genotoxicity risk assessment I. Methods and metrics for defining exposure–response relationships and points of departure (PoDs)

James T. MacGregor, Roland Frötschl, Paul A. White et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 2014 · 129 citations · Full text

, , +17

IWGT report on quantitative approaches to genotoxicity risk assessment II. Use of point-of-departure (PoD) metrics in defining acceptable exposure limits and assessing human risk

James T. MacGregor, Roland Frötschl, Paul A. White et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 2014 · 127 citations · Full text

, , +16

In vitro genotoxicity test approaches with better predictivity: Summary of an IWGT workshop

Stefan Pfuhler, Mick D. Fellows, Jan van Benthem et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 2011 · 113 citations

, , +13

1–5 of 14